baber/WOPTO huggingface dataset:
Patent BR-PI0815273-B1 (BR)
Inventor: BO SHI
IPC: C08L3/02
Filed: 2008-05-19
Abstract: A film that is biodegradable and water-sensitive (e.g., water-soluble, water-dispersible, etc.) in that it loses its integrity over time in the presence of water is provided. The film contains a biodegradable polyester, starch, water-soluble polymer, and plasticizer. The desired water-sensitive attributes of film may be achieved in the present invention by selectively controlling a variety of aspects of the film construction, such as the nature of the components employed, the relative amount of each component, the manner in which the film is formed, and so forth.
Patent BR-PI0909136-B1 (BR)
Title: seleção e re-seleção de células em implantações com nós b nativos
Inventor: FRANCESCO PICA
IPC: H04W12/00
Filed: 2009-03-20
Abstract: SELEÇÃO E RE-SELEÇÃO DE CÉLULAS EM IMPLANTAÇÕES COM NÓS B NATIVOS. São descritos sistemas e metodologias que facilitam busca seleção, e re-seleção de célula dentro de uma rede de comunicação sem fio que inclui um nó de estação base nativo (Nó B nativo). Um equipamento de usuário (UE) pode detectar um Nó B nativo e comunicar esta identificação a uma macro rede que inclui pelo menos um nó de estação base (Nó B). O Nó B nativo detectado e Nó B podem ser estruturados hierarquicamente a fim de priorizar conectividade com o Nó B nativo sobre o Nó B. Esta priorização pode ser implementada através de difusão de parâmetros do Nó B nativo e parâmetros do Nó B macro que tem nela informação de identificação.
Patent BR-PI0909630-B1 (BR)
Title: Composição em suspensão aquosa particularmente adequada para injeção dentro do olho
Inventor: BHAGWATI P KABRA
IPC: A61K47/34
Filed: 2009-03-10
Abstract: composição em suspensão aquosa particularmente adequada para injeção dentro do olho e usos da referida composição a presente invenção refere-se a composição em suspensão de triancinolona acetonidas. as composições em suspensão possuem uma viscosidade relativamente baixa e são fáceis de extrusar através de uma agulha de calibre 27 ou 30, mas são altamente floculadas e facilmente dispersas novamente. as composições são particularmente adequadas para injeção intravitreal.
Patent BR-PI0922072-B1 (BR)
Title: Processo para formatar, encher e selar continuamente bolsas flexíveis com dobras laterais com produto
Inventor: ENDAH SULISTYOWATI
IPC: B65B9/20
Filed: 2009-10-30
Abstract: processo para formatar, encher e selar continuamente bolsas flexíveis com dobras laterais com produto a invenção refere-se a um processo e a um sistema para continuamente formar, encher e selar bolsas flexíveis dotadas de dobras laterais com um produto, compreendendo as etapas de: (i) fornecer uma folha contínua de filme; (ii) estirar a dita folha sobre um molde de bolsa para formar um tubo de filme tendo uma borda do filme vertical sobreposta; (iii) selar a dita borda do filme vertical sobreposta com um selador vertical para formar um selo vertical, enquanto o dito tubo de filme é continuamente puxado em direção da máquina; (iv) formar dobras/sanfonas laterais em ambos os lados do tubo; (v) efetuar um selo horizontal pelo dito tubo de filme, com mandíbulas de selagem horizontal, em local pré-determinado abaixo do dito selo vertical para formar o selo horizontal superior de uma bolsa preenchida e o selo horizontal inferior de uma bolsa a ser preenchida, opcionalmente com perfurações nele; (vi) encher com o dito produto dentro do dito tubo de filme; e, (vii) selar a extremidade aberta do dito tubo de filme com as ditas mandíbulas de selagem em um local pré- - det-ermiaa€1o, --ende-no cruzamento do selo horizontal, com extremidades internas das dobras, uma bolso não-selado estendendo-se em ambos os lados do cruzamento é formada, onde a largura do bolso não-selado está na faixa de 25% a 50% da largura total da dobra.
Patent BR-PI1011559-B1 (BR)
Title: Sistema de impressão a jato de tinta e método para preparar um sistema de cabeçote de impressão
Inventor: ANTHONY SELMECZY
IPC: B41J2/345
Filed: 2010-06-28
Abstract: sistema de impressão a jato de tinta e método para preparar um sistema de cabeçote de impressão a presente invenção refere-se a um sistema de impressão a jato de tinta que inclui um cabeçote de impressão em comunicação fluida com um reservatório de tinta e que tem uma pluralidade de orifícios e uma pluralidade correspondente de câmaras de ejeção associadas. o cabeçote de impressão inclui um substrato e uma camada de barreira disposta no substrato. a camada de barreira define, em parte, uma pluralidade de canais de fluido e a pluralidade de câmaras de ejeção. a camada de barreira inclui um material selecionado dentre materiais fotorresistentes à base de epóxi e materiais fotorresistentes à base de metacrilato de metila. uma placa de orifício é disposta sobre o substrato. a placa de orifício inclui a pluralidade de orifícios em comunicação fluida com as câmaras de ejeção. a placa de orifício compreende um material selecionado dentre poli-imidas e níquel.
Patent CH-717708-B1 (CH)
Title: Behälterverschluss.
Inventor: AHMED MUDASSAR
IPC: B65D55/16
Filed: 2020-06-04
Abstract: Behälterverschluss (11) zum Verschliessen der Ausgiessöffnung (29) eines Behälters (13) mit einem Behälterhals (15), der Behälterverschluss (11) aufweisend eine Verschlusskappe (17) mit einem Aussenmantel (21) einen offenen Rand (25) aufweisend und einer an den Aussenmantel (21) anschliessende ersten Kopfplatte (27). Ferner weist der Behälterverschluss (11) ein Halteelement (19) mit einem Haltering (33) auf, welcher in die Verschlusskappe (17) eingesteckt ist und mit dieser verbunden ist und mit einem Garantiering (39), welcher dazu ausgebildet ist an einem an dem Behälterhals (13) ausgeformten vierten Vorsprung (43) gehalten zu sein. Der Garantiering (39) ist mit einer Mehrzahl von Garantiestegen (45) mit dem Haltering (33) verbunden, wobei das erstmalige Öffnen des Behälterverschlusses (11) durch Bruch der Garantiestege (45) anzeigbar ist. An dem Garantiering (39) ist wenigstens ein erstes Halteband (47) mit einem ersten und einem zweiten Ende und einem ersten und zweiten Rand ausgebildet. Das erste Ende ist mit dem Haltering (33) fest verbunden, das zweite Ende ist mit dem Garantiering (39) fest verbunden, der erste Rand ist mit wenigstens einem ersten Sollbruchsteg mit dem Haltering (33) lösbar verbunden und der zweite Rand ist mit wenigsten einem zweiten Sollbruchsteg mit dem Garantiering (39) lösbar verbunden.
Patent EA-002742-B1 (EA)
Title: Leukotriene antagonists for oral squamous cell carcinoma
Inventor: FLEISCH JEROME H
IPC: C07D221/12
Filed: 1997-12-02
Abstract: 1. A method for treating or inhibiting oral squamous cell carcinoma in a mammal which comprises administering to a mammal in need thereof an effective amount of a compound of the formula   or a pharmaceutically acceptable salt thereof of an addition base, wherein R1 is C1-C5 alkyl, C1-C4 alkenyl, (C1-C4 alkyl)thio, halo, or R2 substituted phenyl; each R2 and R1 are each independently hydrogen, halo, hydroxy, C1-C4 alkyl, C1-C4 alkoxy; Y and X are -O- or -CH2-; Z is CH2-CH2 or CH2CH2CH2CH2; A is -O-, -CH2-, CH(R7-substituted phenyl)- or -C(CH3)2-; R4 is    each R7 is hydrogen, C1-C4-alkyl, R8 is hydrogen or halogen; and with the proviso that when X is -O-, Y is not O. 2. The method as claimed in Claim 1, wherein a compound is 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid or a pharmaceutically acceptable salt or solvate thereof. 3. The method as claimed in Claim 1, wherein a compound is 3-(2-(3-(2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy)propoxy)-6-(4-carboxy-phenoxy)phenyl)propionic acid or a pharmaceutically acceptable salt or solvate thereof. 4. The method as claimed in Claim 1, wherein a compound is 1-(4-(carboxy-methoxy)phenyl)-1-(1H-tetrazol-5-yl)-6-(2-ethyl4- (4-fluorophenyl) -5-hydroxyphenoxy)hexane or a pharmaceutically acceptable salt or solvate thereof. 5. The method as claimed in Claim 1, wherein a compound is 3-[4-[7-carboxy-9-oxo-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxyi -propoxy] -9H-xanthene] ] propanoic acid or a pharmaceutically acceptable salt or solvate thereof. 6. The method as claimed in Claim 1, wherein a compound is 5- [3-[2-(1-carboxy)-ethyl]-4-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy] -propoxy] phenyl] -4-pentynoic acid or a pharmaceutically acceptable salt or solvate thereof. 7. The method as claimed in Claims 1 to 6 in which the mammal is a human.
Patent EA-007563-B1 (EA)
Title: Pectin film composition
Inventor: SCOTT ROBERT
IPC: C08L89/06
Filed: 2001-08-21
Abstract: The invention concerns film-forming compositions containing pectin, at least one additional film-forming polymer and a setting system for use in pharmaceutical, veterinary, food, cosmetic or other products like films for wrapping food, aspics or jellies, preferably for predosed formulations like soft or hard capsules, as well as aqueous solutions of the compositions for the manufacturing of said products.
Patent EA-004826-B1 (EA)
Title: Dosing device
Inventor: HAFNER HANS WILHELM
IPC: B65G53/46
Filed: 2002-02-08
Abstract: 1. A dosing apparatus for the continuous, gravimetric dosing of bulk material, especially powdery fuels, with a stream of material being conveyed with a dosing rotor driven about a swiveling axis under determination of the momentary load over a measuring section from a charge opening to an offset discharge opening, and with a load-sensing apparatus which detects the momentary load of the stream of material guided over the measuring section, characterized in that at least one second dosing rotor (33) is arranged on the same axis with a discharge opening (37) which is offset to an intermediate opening (7). 2. A dosing apparatus as claimed in claim 1, characterized by the configuration as dosing rotors (3, 33) with substantially radially extending driving webs (11). 3. A dosing apparatus as claimed in claim 2, characterized in that the driving webs (11) are connected at their radially outside ends with an outer ring (14). 4. A dosing apparatus as claimed in claim 3, characterized in that the outer ring (14) of the dosing rotors (3, 33) has a slightly smaller diameter than the diameter of the housing (4) by forming a circumferential gap. 5. A dosing apparatus as claimed in one of the claims 1 to 4, characterized in that the first or upper dosing rotor (3) revolves on an intermediate wall (23) of the housing (4), which intermediate wall comprises the intermediate opening (7). 6. A dosing apparatus as claimed in one of the claims 1 to 5, characterized in that the first or upper dosing rotor (3) has a lower height than the second lower dosing rotor (33). 7. A dosing apparatus as claimed in one of the claims 2 to 6, characterized in that the second or subsequent dosing rotor (33) is driven at a higher rotational speed than the first dosing rotor (3). 8. A dosing apparatus as claimed in one of the claims 1 to 7, characterized in that the intermediate opening (7) and the discharge opening (37) are mutually offset by 180 degree . 9. A dosing apparatus as claimed in one of the claims 1 to 8, characterized in that the charge opening (5) and the discharge opening (37) are mutually offset by 360 degree or more, especially by 540 degree in the case of three or 720 degree in the case of four dosing rotors.
Patent EA-006235-B1 (EA)
Title: Insect repellent
Inventor: BENCSITS FRANZ
IPC: A01N31/06
Filed: 2002-07-23
Abstract: The invention relates to the hydrated compound of an unsaturated monoterpenoid and to the use thereof as insect repellent.
Patent EA-008772-B1 (EA)
Title: Method for treating hernia of intervertebral disks
Inventor: SOLOMATOV VIKTOR GENNADIEVICH
IPC: A61H23/00
Filed: 2005-05-20
Abstract: The invention relates to medicine, in particular, to energy reflexotherapy and can be used for treating hernia of intervertebral disks.According to the results of express diagnostics of the herniae of intervertebral disks vibrostimulation of biologically-active points and/or zones of reflexotherapy is carried out in projection of spinal nerves outlets from vertebral canal in affected interbertebral segment and/or in neigbouring interbertebral segments and/or in extremities and corporeal biologically-active points and/or zones od reflexotherapy alongwith corresponding tendomuscular meridians; at least 2 courses of treatment including 10-15 procedures are performed , the first five days–daily, after that daily or in one-three days with compulsory intervals between courses-from 10 to21 days, between the second and the third courses-between 21 to 60 days depending upon patient condition ( the worse patient state the shorter interval).
Patent EA-007756-B1 (EA)
Title: Device for effecting continuous gravimetric dosing
Inventor: WOLFSCHAFFNER HUBERT
IPC: G01G11/08
Filed: 2004-02-25
Abstract: A device for effecting continuous gravimetric dosing and determining the mass flow rate of free-flowing products with a dosing apparatus, with determination of the momentary mass flow rate before a delivery point by means of a dosing controller, with the delivery control occurring by changing the speed of a drive of the doing apparatus by means of a motor controller, characterized in that the dosing controller (10) and the motor controller (20) are joined into a subassembly (G).
Patent EA-013473-B1 (EA)
Title: Process for producing tricyclic ketone
Inventor: NISHIYAMA HIROYUKI
IPC: C07D213/64
Filed: 2006-06-08
Abstract: In order to efficiently supply CPT, which is a starting compound for producing irinotecan hydrochloride and a variety of camptothecin derivatives, by a practical total synthesis, the invention provides a means of efficiently producing a tricyclic ketone that corresponds to a CDE ring moiety of a camptothecin (CPT) skeleton.
Patent EA-011429-B1 (EA)
Title: Wireless transmitting device and wireless transmitting device
Inventor: IMAMURA KIMIHIKO
IPC: H04B7/06
Filed: 2006-09-01
Abstract: A wireless transmitting device is provided with n number of transmitting antennas (n is an integer of 2 or more); and a delay adding section, which delays a transmission signal to be supplied to the n number of transmitting antennas by a maximum delay time ((n-1)T or less, based on a delay time (T) corresponding to a notification signal for notifying whether the transmission signal is to be transmitted by frequency diversity or by multi-user diversity.
Patent EA-015075-B1 (EA)
Title: Rotating device for producing pressure
Inventor: SKOMSVOLD AGE JORGEN
IPC: F02C5/04
Filed: 2007-12-27
Abstract: A rotating device for producing pressure from a process substance by expansion, which device includes a U-channel structure (120) rotatably arranged on an axis (121,122) including an expansion point (105) arranged at the periphery of the rotating device, a sinking channel (104) for delivery of compressed process substance to said expansion point (105), a rising channel (107) for delivery of expanded process substance from said expansion point (105) to a regulating valve (110) for delivery of said process substance under high pressure to an outlet channel (112) for said compressed process substance to an energy recovery device, driving devices in order to rotate said U-channel structure (120) around the axis (121, 122).
Patent EA-019258-B1 (EA)
Title: COMPOSITIONS COMPRISING COAGULATION FACTOR VIIa MODULATORS AND USES THEREOF
Inventor: LOURY DAVID
IPC: A61K35/14
Filed: 2008-10-16
Abstract: A composition is proposed suitable for subcutaneous administration to a mammal, the composition comprises a compound of formula I or a salt thereof dissolved in water, sodium hydroxide and tromethamine and having a pH between about 8.0 and about 9.5. The composition is for use in the treatment of cancer and thromboembolic disorders. A device is also proposed comprising a syringe for administering the composition according to the invention.
Patent EA-022387-B1 (EA)
Title: Dialysis solution comprising creatine compound, kit and solid preparation for manufacturing the same
Inventor: KIRSCHNER ULRICH
IPC: A61P7/08
Filed: 2010-07-21
Abstract: The invention relates to a dialysis solution for haemodialysis or peritoneal dialysis, comprising a creatine compound in concentration of 0.1-5.0 mmol/L, one or more electrolytes and having a theoretical osmolarity within the range of from 250 to 550 mosm/L and a pH value within the range of from 4.9 to 8.0, and also to a kit and to a solid preparation for manufacturing said dialysis solution. Use of a creatine compound for the manufacture of a dialysis solution provides cells protection and counteraction to pathophysiological states that occur in haemodialysis patients.
Patent EA-020270-B1 (EA)
Title: Solid dosage form having a choleretic effect (variants)
Inventor: CHELYAEVA ANASTASIYA GENNADIEVNA
IPC: A61K9/20
Filed: 2012-10-04
Abstract: The invention relates to the pharmaceutical industry and medicine and can be used in the creation and administration of solid dosage forms having a choleretic effect. The present invention addresses the problem of creating an effective solid dosage form having a choleretic effect. In the description, two variants of the invention are claimed which solve the problem of interest in that the solid dosage form contains dried bile, mineral substances and a pharmaceutically acceptable carbon-containing additional substance with carbonC isotopes. The invention achieves the technical results of a greater and more rapid therapeutic effect in the treatment of liver and gall bladder diseases without decreasing the duration of said therapeutic effect or increasing the concentration of bile.
Patent EA-027698-B1 (EA)
Title: Chromium oxide powder
Inventor: LINNOT CYRIL
IPC: C04B35/66
Filed: 2011-07-22
Abstract: The invention relates to a particulate powder, said powder having a median circularity of greater than 0.87 and less than 9.0 wt.% of particles having a size greater than 100 μm. The powder and at least 80 wt.% of the particles have a chemical composition such that, in wt.% on the basis of the oxides and for a total of 100%: CrO+AlO+ZrO+MgO+FeO+SiO+TiO≥90%; CrO+AlO+MgO≥60%; CrO≥9%; 20%≥SiO≥0,5%; and other oxides ≤10%. The invention can be used for a glass furnace.
Patent EA-029494-B1 (EA)
Title: Topical steroid composition and method
Inventor: JOHNSON KEITH A
IPC: A61K47/14
Filed: 2013-10-16
Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
Patent EA-031595-B1 (EA)
Title: Thermally insulating stretchable down feather sheet and method of fabrication thereof
Inventor: REUBEN RONIE
IPC: A41D31/00
Filed: 2014-11-19
Abstract: The present invention relates to a thermally insulating stretchable down feather sheet and a method of manufacture thereof. The core of the sheet is comprised of down feathers mixed with a binder which exhibits elastic properties. The core is sandwiched between a top and bottom stretchable elastomeric sheet having multidirectional stretchability. The core down feathers and the binder as well as the elastomeric sheet and bound together by heat treatment to provide a down feather insulating sheet which is stretchable in all directions without fractioning the sheet.
Patent EA-032328-B1 (EA)
Title: Hinged lid package for smoking and/or tobacco related articles, blank and method therefor
Inventor: KNUDSEN JOERG
IPC: B65D5/52
Filed: 2014-10-14
Abstract: The present invention relates to a hinged lid package (1) for elongate articles (21), a blank and a method for manufacturing the package (1). The package (1) comprises a body (2) having a rear wall (8), a bottom wall and two side walls (6, 15), the package (1) further comprising a lid (3) which is hinged to the body (2) by a first hinge (10), the lid (3) and the body (2) being coupled such that the body (2) can rest on the lid (3) in the open end position of the lid (3) and the lid (3) remains open, wherein the package (1) further comprises a second hinge (11) inside the rear wall (8) of the body (2).
Patent EA-038254-B1 (EA)
Title: Treatment of central nervous system tumours
Inventor: DE VLEESCHOUWER STEVEN
IPC: A61K9/51
Filed: 2016-11-23
Abstract: The invention generally relates to a new formulation containing nanoparticles encapsulating siRNA for the use of RNAi technology for gene silencing of galectin-1 involved in tumour progression. More in particular the invention relates to the use of RNAi molecules for treating central nervous cancer, more in particular for treating glioblastoma multiforme (GBM).
Patent EA-035937-B1 (EA)
Title: Secure item identification based on physical label properties
Inventor: FRADET ERWAN
IPC: G06Q30/00
Filed: 2016-12-23
Abstract: The present invention relates to methods, network devices, and machine-readable media for an integrated environment for generating a secure item identification code associated with or based on a measured physical property of an item, such as a label or a stamp.
Patent EA-037800-B1 (EA)
Title: In-situ process to produce hydrogen from underground hydrocarbon reservoirs
Inventor: GATES IAN D
IPC: E21B43/295
Filed: 2017-02-07
Abstract: A hydrocarbon reservoir is treated with heat to induce gasification, water-gas shift, and/or aquathermolysis reactions to generate gases including hydrogen. The hydrogen alone is produced to the surface by using hydrogen-only membranes in the production wells.
Patent ES-2160534-B1 (ES)
Title: Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
Inventor: HUGUET CLOTET JUAN
IPC: C07C215/42
Filed: 1999-12-30
Granted: 2002-04-16
Abstract: Nuevos ésteres derivados de (RR, SS)-2-hidroxibenzoato de 3-(2- dimetilaminometil-1-hidroxiciclohexil) fenilo, análogos al Tramadol, procedimiento para su obtención y uso de dichos compuestos para la fabricación de un medicamento con propiedades analgésicas. Estos nuevos productos de fórmula general (I) presentan una actividad analgésica superior al tramadol.
Patent ES-2181557-B1 (ES)
Title: Sistema de alimentacion de motores y recarga de baterias en vehiculos electricos.
Inventor: IBANEZ DE ALBA ANTONIO
IPC: H02J7/02
Filed: 2000-11-27
Granted: 2004-06-01
Abstract: Sistema de alimentación de motores y recarga de baterías en vehículos eléctricos. Se caracteriza porque en la calzada (7) se dispone al menos una bobina (6) de una cierta longitud que es alimentada por un generador de frecuencia (8) para producir en sus inmediaciones un campo electromagnético. Los vehículos (1) cuentan con al menos una bobina (2) que al situarse sobre el campo electromagnético induce una corriente alterna, la cual es convertida a corriente continua mediante un convertidor (3) para alimentar el motor(es) y recargar la(s) batería(s) (4) del vehículo, bien cuando circula o cuando está estacionado sobre la bobina (6). En una realización la bobina (2a) está ubicada en los bajos del vehículo para facilitar la recarga. En otra realización la bobina (2b) está ubicada en la rueda del vehículo.